Clinical trial
Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary…
NCT00453414 · Actelion, Industry · Withdrawn
Key facts
| NCT number | NCT00453414 |
|---|---|
| Title | Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension |
| Official title | Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension |
| Lead sponsor | Actelion, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Arterial Hypertension |
| Intervention type | Drug |
| Interventions | Iloprost Inhalation Solution (Ventavis) |
| Enrollment | 0 |
| Start date | Jul 1, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Mar 29, 2007 |
| Last update posted | Feb 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: